Senior insider sale
Senior Vice President, R&D at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$477.2K
11.86K shares
What this filing means
ROTE WILLIAM E. plans to sell 11.86K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $477.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/6/2026ACC: 0001959173-26-003306
Officer· Senior Vice President, R&D
Since Nov 2018
11.86K
Shares to sell
$477.2K
Approx. market value
2.76K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/4/2026
2.76KTotal acquired2.76K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Restricted Stock Vesting Compensation | 2.76K | — |
| Total | 2.76K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
9.10K
Market value
$355.7K
4/22/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.76K
Market value
$121.4K
5/6/2026
Total
Units
11.86K
Value
$477.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/22/2026 | 9.10K | $355.7K | — | Completed |
| Planned — Approximate Date | ||||
5/6/2026 | 2.76K | $121.4K | NASDAQ | Planned |
| Total | 11.86K | $477.2K | ||